GO:0042361 menaquinone catabolic process: Vitamin K2 Degradation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042361 menaquinone catabolic process describes the biochemical breakdown of menaquinones (vitamin K2), quinone-derived compounds synthesized by intestinal bacteria.
• Menaquinones are characterized by a methylated naphthoquinone ring and a variable-length unsaturated isoprenoid side chain, which determines their catabolic fate.
• Menaquinone catabolism is essential for vitamin K homeostasis and for generating intermediates used in electron transport and redox balancing [1,6].
• Microbial menaquinone degradation and modification pathways, including methylmenaquinone biosynthesis and catabolism, are increasingly recognized in host-microbiome interactions.
• Dysregulation of menaquinone metabolism has been linked to cardiovascular calcification, diabetes-related oxidative stress, and altered matrix Gla protein activity [2,3,8].
• CRISPR knockout, knock-in, and overexpression models enable precise interrogation of genes involved in menaquinone catabolic process in human and microbial systems [5,6].
Description
Menaquinone catabolic process (GO:0042361) is defined as the chemical reactions and pathways resulting in the breakdown of menaquinones, a class of quinone-derived compounds synthesized primarily by intestinal bacteria. Menaquinones, also known as vitamin K2, consist of a methylated naphthoquinone ring structure and side chains composed of a variable number of unsaturated isoprenoid residues. This catabolic process is critical for maintaining vitamin K homeostasis and for recycling or eliminating menaquinone species within microbial and host systems [1,6]. Understanding menaquinone catabolism has broad implications for microbiology, nutrition, and human disease, particularly in conditions where vitamin K status influences cardiovascular health and glucose metabolism [2,3,8]. Recent structural and biochemical studies have begun to elucidate the enzymes and membrane-bound complexes that catalyze key steps in menaquinone breakdown, including menaquinol:organohalide oxidoreductases. Moreover, microbial methylmenaquinone biosynthesis and degradation pathways are being actively investigated for their roles in anaerobic respiration and host-microbe interactions. This article synthesizes current knowledge on the menaquinone catabolic process, highlighting the genes, mechanisms, and experimental models that researchers can use to study this pathway.
menaquinone catabolic process At A Glance
| GO ID | GO:0042361 |
|---|---|
| GO term | menaquinone catabolic process |
| Ontology | biological_process |
| Synonym | menaquinone breakdown; menaquinone catabolism; menaquinone degradation; menatetrenone catabolic process; menatetrenone catabolism; multiprenylmenaquinone catabolic process; multiprenylmenaquinone catabolism; vitamin K2 catabolic process; vitamin K2 catabolism |
| Major function | Breakdown of menaquinones (vitamin K2) to regulate vitamin K homeostasis and generate metabolic intermediates |
| Definition | The chemical reactions and pathways resulting in the breakdown of menaquinones, any of the quinone-derived compounds synthesized by intestinal bacteria. |
| Related compounds | Menaquinone-4 (menatetrenone), menaquinone-7, methylmenaquinones |
| Cellular context | Microbial membranes and host tissues; often associated with electron transport chains |
What Is GO:0042361?
The menaquinone catabolic process (GO:0042361) encompasses all biochemical reactions that lead to the breakdown of menaquinones, which are vitamin K2 compounds produced by intestinal bacteria. These molecules feature a methylated naphthoquinone core and an isoprenoid side chain of variable length. Catabolism of menaquinones involves oxidative cleavage, side-chain modification, and conjugation reactions that convert these lipophilic quinones into more polar metabolites for excretion or recycling. This process is distinct from menaquinone biosynthesis and is essential for regulating vitamin K2 levels in biological systems.
Why Is menaquinone catabolic process Important in Cell Biology?
The menaquinone catabolic process is important because menaquinones are essential for vitamin K-dependent carboxylation of proteins such as matrix Gla protein, and their breakdown directly influences the availability of active vitamin K2 [2,3]. Dysregulated menaquinone catabolism can lead to altered vitamin K status, which has been associated with cardiovascular calcification, diabetes-related oxidative stress, and other metabolic disorders [2,8]. In microbial systems, menaquinone degradation and modification pathways are critical for anaerobic respiration and for the production of methylmenaquinones that function in electron transport. Understanding this process at the molecular level provides insights into host-microbiome interactions and offers potential therapeutic targets for diseases linked to vitamin K imbalance [1,6].
• Regulates vitamin K2 homeostasis and prevents excessive accumulation of menaquinones in tissues.
• Influences matrix Gla protein activation, which is critical for preventing vascular calcification.
• Menaquinone-7 supplementation alters circulating matrix Gla protein species, highlighting the interplay between intake and catabolism.
• Microbial menaquinone catabolism contributes to anaerobic respiration and redox balance in the gut microbiome.
• Menaquinone catabolic intermediates may serve as biomarkers for oxidative stress and glycation in diabetes.
• Structural studies of menaquinol:organohalide oxidoreductases reveal mechanisms of menaquinone transformation in pathogens.
• Vitamin K2 catabolism affects the bioavailability of menaquinone-7 from dietary supplements.
• Dysregulation of menaquinone metabolism is implicated in cardiovascular disease and metabolic syndrome [1,8].
• CRISPR-based models enable functional dissection of genes involved in menaquinone catabolic process [5,6].
• Understanding menaquinone catabolism can guide development of probiotics or therapeutics targeting vitamin K status [1,6].
What Happens During menaquinone catabolic process?
Initial oxidative cleavage of the naphthoquinone ring
In simple terms: The first step in breaking down menaquinone is cutting open its ring structure.
The catabolic process begins with oxidative cleavage of the methylated naphthoquinone ring, which is catalyzed by enzymes such as menaquinol:organohalide oxidoreductases that activate molecular oxygen or other electron acceptors. This step converts the lipophilic menaquinone into more polar intermediates, facilitating further degradation.
Side-chain modification and shortening
In simple terms: The long isoprenoid tail of menaquinone is trimmed down.
Following ring cleavage, the unsaturated isoprenoid side chain undergoes oxidative modification and shortening. Enzymes involved in beta-oxidation-like reactions remove isoprene units, generating menaquinone metabolites with shorter chains [1,6]. These modifications are essential for the eventual excretion or recycling of menaquinone carbon skeletons.
Conjugation and excretion
In simple terms: The broken-down pieces are tagged for removal from the body.
The resulting menaquinone catabolites are conjugated with glucuronic acid or sulfate groups, increasing their water solubility for renal or biliary excretion. This phase is critical for preventing the accumulation of potentially toxic quinone intermediates and for maintaining vitamin K homeostasis.
Microbial menaquinone catabolism and methylmenaquinone turnover
In simple terms: Bacteria also break down their own menaquinones to recycle components.
In intestinal bacteria, menaquinone catabolism is intertwined with methylmenaquinone biosynthesis and degradation. Microbial enzymes can demethylate or modify the menaquinone ring, allowing recycling of the naphthoquinone core for new menaquinone synthesis. This turnover is important for maintaining electron transport chain function under changing environmental conditions.
Regulation by vitamin K status and oxidative stress
In simple terms: The body adjusts how fast it breaks down menaquinone based on vitamin K levels and stress.
Menaquinone catabolic flux is regulated by vitamin K status and oxidative stress. High menaquinone intake can upregulate catabolic enzymes to prevent excess accumulation, while oxidative stress may accelerate non-enzymatic degradation [1,8]. This regulation ensures a balance between vitamin K2 availability and elimination.
Key Genes Involved in GO:0042361 menaquinone catabolic process
The following genes and proteins have been implicated in menaquinone catabolic process or related menaquinone metabolism pathways based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| menA | Menaquinone biosynthesis and modification | Studied for menaquinone turnover in bacteria |
| menB | Naphthoquinone ring synthesis | Target for understanding catabolic intermediates |
| menC | Menaquinone biosynthesis | Potential role in menaquinone degradation pathways |
| menD | Menaquinone biosynthesis | Model for menaquinone metabolic engineering |
| menE | Menaquinone biosynthesis | Linked to menaquinone catabolism in microbes |
| menF | Menaquinone biosynthesis | Studied in methylmenaquinone pathways |
| menG | Methyltransferase for menaquinone | Affects menaquinone catabolic flux |
| menH | Menaquinone biosynthesis | Potential catabolic regulator |
| menI | Menaquinone biosynthesis | Involved in menaquinone modification |
| ubiE | Methyltransferase in quinone metabolism | Cross-talk with menaquinone catabolism |
| MGP | Matrix Gla protein, vitamin K-dependent | Marker of menaquinone catabolism impact |
| VKORC1 | Vitamin K epoxide reductase | Regulates vitamin K cycle and menaquinone levels |
| GGCX | Gamma-glutamyl carboxylase | Uses menaquinone as cofactor |
| CYP4F2 | Vitamin K oxidase | Involved in vitamin K catabolism |
| UGT1A | UDP-glucuronosyltransferase | Conjugates menaquinone catabolites |
| SULT | Sulfotransferase | Phase II conjugation of menaquinone metabolites |
| rdhA | Reductive dehalogenase | Menaquinol:organohalide oxidoreductase component |
How Is menaquinone catabolic process Regulated?
Menaquinone catabolic process is regulated at multiple levels. Vitamin K status influences the expression and activity of catabolic enzymes, with high menaquinone intake leading to increased catabolism to maintain homeostasis. Oxidative stress can accelerate non-enzymatic menaquinone degradation and modulate enzyme activity. In microbial systems, menaquinone catabolism is regulated by environmental factors such as oxygen availability and the presence of alternative electron acceptors, which affect the expression of menaquinone-modifying enzymes. Additionally, the vitamin K cycle, involving VKORC1 and GGCX, indirectly controls menaquinone availability and thus catabolic flux.
menaquinone catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MGP | Cardiovascular calcification | MGP knockout mouse or vascular smooth muscle cell model |
| VKORC1 | Vitamin K-dependent coagulation disorders | VKORC1 knockout or point-mutation cell lines |
| GGCX | Vitamin K-dependent carboxylation deficiency | GGCX knockout hepatocytes |
| CYP4F2 | Vitamin K metabolism and hypertension | CYP4F2 overexpression in HepG2 cells |
| rdhA | Organohalide respiration and infection | Bacterial rdhA knockout strains |
Cardiovascular calcification and menaquinone catabolism
Menaquinone catabolism affects the availability of vitamin K2 for carboxylation of matrix Gla protein (MGP), a potent inhibitor of vascular calcification. Studies show that menaquinone-7 supplementation alters circulating species of MGP, indicating that catabolic processes influence MGP activation. Dysregulated menaquinone catabolism may therefore contribute to arterial calcification and cardiovascular disease [1,2].
Diabetes and oxidative stress
In Zucker diabetic fatty rats, menaquinone-7 supplementation increased multiple advanced glycation end-products and oxidation markers, suggesting that menaquinone catabolism interacts with oxidative stress pathways in diabetes. This highlights the potential role of menaquinone catabolic process in metabolic disorders.
Microbial infections and menaquinone catabolism
Menaquinone catabolic enzymes, such as menaquinol:organohalide oxidoreductases, are important for the metabolism of organohalide compounds in pathogenic bacteria. Understanding these pathways can inform the development of antimicrobial strategies targeting menaquinone turnover [5,6].
From menaquinone catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate menaquinone catabolic flux? | CRISPR knockout in HepG2 or Caco-2 cells |
| What is the effect of a point mutation in a catabolic enzyme? | CRISPR point-mutation knock-in in cell lines |
| How does overexpression of a catabolic gene affect vitamin K levels? | CRISPR overexpression (CRISPRa) in mammalian cells |
| Where is the catabolic enzyme localized? | Tagged knock-in with fluorescent protein |
| Which microbial genes are essential for menaquinone degradation? | CRISPR knockout in Bacteroides or E. coli |
| Can menaquinone catabolism be modulated by diet? | Mouse models with menaquinone-7 supplementation |
How to Study the menaquinone catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Menaquinone and catabolite levels | Quantifying vitamin K2 degradation [1,2] |
| CRISPR knockout screening | Gene essentiality for catabolism | Identifying novel catabolic genes [5,6] |
| RNA-seq | Transcriptional changes | Pathway regulation under stress [1,8] |
| Proteomics | Protein abundance and modifications | Enzyme expression profiling |
| Enzymatic assays | Catalytic activity and kinetics | Characterizing catabolic enzymes |
| Fluorescence microscopy | Subcellular localization | Tagged catabolic enzymes |
| Metabolomics | Global metabolite changes | Pathway flux analysis |
LC-MS/MS for menaquinone metabolite profiling
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for quantifying menaquinone species and their catabolites in biological samples. This method enables researchers to track the breakdown of menaquinone-4 and menaquinone-7 and identify novel catabolic intermediates [1,2].
CRISPR screening for catabolic gene discovery
Genome-wide CRISPR knockout or activation screens can identify genes that regulate menaquinone catabolic process. By coupling menaquinone-sensitive reporters or metabolite measurements with pooled screens, researchers can uncover novel catabolic enzymes and regulators [5,6].
Transcriptomics and proteomics
RNA-seq and quantitative proteomics can reveal changes in gene expression and protein abundance associated with menaquinone catabolism under different conditions, such as vitamin K supplementation or oxidative stress [1,8].
Enzymatic assays with recombinant proteins
Recombinant expression and purification of candidate menaquinone catabolic enzymes allow in vitro biochemical assays to determine substrate specificity, cofactor requirements, and kinetic parameters [5,6].
How CRISPR Can Be Used to Study GO:0042361 menaquinone catabolic process
Knockout
CRISPR knockout of candidate menaquinone catabolic genes (e.g., CYP4F2, UGT1A) in human cell lines can reveal their contribution to vitamin K2 homeostasis. Knockout models are essential for determining whether a gene is required for menaquinone breakdown and for assessing downstream effects on MGP carboxylation [1,2].
Point Mutation
CRISPR point-mutation knock-in allows precise modeling of single-nucleotide variants in catabolic enzymes, such as those in VKORC1 or GGCX, to study their impact on menaquinone catabolic flux and disease susceptibility.
Knock-in
Tagged knock-in of catabolic enzymes with fluorescent or affinity tags enables real-time tracking of protein localization and interaction partners in living cells, providing insights into the spatial organization of menaquinone catabolism.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of menaquinone catabolic genes can model states of enhanced catabolism, useful for studying the consequences of accelerated vitamin K2 breakdown in metabolic and cardiovascular disease [1,8].
How EDITGENE Supports menaquinone catabolic process Research
Researchers studying menaquinone catabolic process-related genes often need to determine whether a candidate gene is causally involved in vitamin K2 breakdown, how mutations affect enzyme function, and whether modulating its expression alters disease phenotypes. EDITGENE provides end-to-end CRISPR services to accelerate these investigations.
Contact EDITGENE today to design your custom CRISPR model for menaquinone catabolic process research.
Frequently Asked Questions About menaquinone catabolic process
What is menaquinone catabolic process?
Menaquinone catabolic process (GO:0042361) is the set of biochemical reactions that break down menaquinones, also known as vitamin K2, which are synthesized by intestinal bacteria.
What genes are involved in menaquinone catabolic process?
Genes such as CYP4F2, UGT1A, VKORC1, GGCX, and microbial men genes (menA-menI) are involved in menaquinone metabolism and catabolism [1,6].
How is menaquinone catabolism regulated?
It is regulated by vitamin K status, oxidative stress, and the vitamin K cycle involving VKORC1 and GGCX [1,8].
What diseases are linked to menaquinone catabolic process?
Dysregulation is linked to cardiovascular calcification, diabetes-related oxidative stress, and microbial infections [2,5,8].
What is the role of menaquinone-7 in catabolism?
Menaquinone-7 is a vitamin K2 subtype whose catabolism affects circulating matrix Gla protein species and vitamin K status [2,3].
How can I study menaquinone catabolic process in the lab?
LC-MS/MS, CRISPR screening, RNA-seq, and enzymatic assays are commonly used to study menaquinone catabolism [1,5,6].
What are the synonyms for menaquinone catabolic process?
Synonyms include menaquinone breakdown, menaquinone catabolism, menaquinone degradation, vitamin K2 catabolic process, and menatetrenone catabolism.
Which model organisms are used to study menaquinone catabolism?
Human cell lines (HepG2, Caco-2), mice, and bacteria such as Bacteroides and E. coli are used [5,6,8].
What is the connection between menaquinone catabolism and vitamin K2?
Menaquinones are vitamin K2; their catabolism regulates vitamin K2 levels and availability for carboxylation reactions.
Can CRISPR be used to study menaquinone catabolic process?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise functional studies of genes in this pathway [5,6].
Conclusion
Menaquinone catabolic process (GO:0042361) is a critical biological pathway for regulating vitamin K2 homeostasis and generating metabolites with diverse physiological roles. Dysregulation of this process has been implicated in cardiovascular disease, diabetes, and microbial pathogenesis [1,2,5,8]. Advances in CRISPR-based models and analytical methods are accelerating the discovery of genes and mechanisms underlying menaquinone catabolism. Continued research in this area promises to uncover new therapeutic targets and biomarkers for vitamin K-related disorders.
References
- 1. Halder M et al.. 2019. Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease.. Int J Mol Sci 20(4) PMID: 30791399
- 2. Dalmeijer GW et al.. 2012. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.. Atherosclerosis 225(2):397-402 PMID: 23062766
- 3. Schurgers LJ et al.. 2007. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.. Blood 109(8):3279-83 PMID: 17158229
- 5. Cimmino L et al.. 2023. Structure of a membrane-bound menaquinol:organohalide oxidoreductase.. Nat Commun 14(1):7038 PMID: 37923808
- 6. Wilkens D et al.. 2023. Biosynthesis and function of microbial methylmenaquinones.. Adv Microb Physiol 83:1-58 PMID: 37507157
- 8. Mrosewski I et al.. 2025. Menaquinone-7 Supplementation Increases Multiple Advanced Glycation End-Products and Oxidation Markers in Zucker Diabetic Fatty Rats.. Nutrients 17(17) PMID: 40944124
